Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date Cardiac Transthyretin Amyloid (ATTR) FellowshipRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)Release Date:Research Hospital All Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets AsiaEducation Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam Improving Real-World Evidence & Data Generation Skills in Latin AmericaRelease Date:Education Support for the Professions All Optimizing Venous Thromboembolism Management in Latin AmericaRelease Date:Quality Improvement Internal Medicine All Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)Release Date:Research Inflammation & Immunology All Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited SettingsRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Hospital All Increase HCP knowledge of Gene Therapy managementRelease Date:Education Rare Disease China Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)Release Date:Research Vaccines All Pre-clinical & Translational Research in Multiple MyelomaRelease Date:Research Oncology All Best Practices in HR+HER2-Metastatic Breast Cancer Medical Management Latin America,Africa,Middle East,Asia Pacific except ChinaRelease Date:Education Oncology All